Literature DB >> 12739107

Non-fatal acute liver injury possibly related to high-dose ciprofloxacin.

M Goetz1, P R Galle, A Schwarting.   

Abstract

Fulminant hepatic failure is an uncommon but life-threatening adverse reaction to antibiotic therapy. Reported here is a case of severe liver injury associated with ciprofloxacin administered for treatment of a gram-negative infection in a 79-year-old female. The patient presented with metabolic acidosis 48 hours after the first ciprofloxacin intake. Symptoms resolved after cessation of ciprofloxacin therapy. This report highlights an uncommon side effect of a commonly used antimicrobial agent.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12739107     DOI： 10.1007/s10096-003-0914-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


  7 in total

1.  Clinical assessment of drug-induced disease.

Authors:  R S Gruchalla
Journal:  Lancet       Date:  2000-10-28       Impact factor: 79.321

2.  Severe ciprofloxacin-induced acute hepatitis.

Authors:  M A Contreras; R Luna; J Mulero; J L Andreu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-06       Impact factor: 3.267

Review 3.  Criteria of drug-induced liver disorders. Report of an international consensus meeting.

Authors:  C Bénichou
Journal:  J Hepatol       Date:  1990-09       Impact factor: 25.083

4.  Fulminant hepatic failure possibly related to ciprofloxacin.

Authors:  B K Grassmick; V T Lehr; A S Sundareson
Journal:  Ann Pharmacother       Date:  1992-05       Impact factor: 3.154

5.  Cholestatic hepatitis related to quinolones: a report of two cases.

Authors:  M L Hautekeete; M M Kockx; S Naegels; J K Holvoet; H Hubens; G Kloppel
Journal:  J Hepatol       Date:  1995-12       Impact factor: 25.083

6.  Fatal hepatic failure associated with ciprofloxacin.

Authors:  S Fuchs; Z Simon; M Brezis
Journal:  Lancet       Date:  1994-03-19       Impact factor: 79.321

Review 7.  Overview of fluoroquinolone safety.

Authors:  J S Wolfson; D C Hooper
Journal:  Am J Med       Date:  1991-12-30       Impact factor: 4.965
  7 in total
  6 in total

1.  Clinical and histopathologic features of fluoroquinolone-induced liver injury.

Authors:  Eric S Orman; Hari S Conjeevaram; Raj Vuppalanchi; James W Freston; James Rochon; David E Kleiner; Paul H Hayashi
Journal:  Clin Gastroenterol Hepatol       Date:  2011-02-26       Impact factor: 11.382

Review 2.  Practical guidelines for diagnosis and early management of drug-induced liver injury.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

Review 3.  Ciprofloxacin-induced acute liver injury: case report and review of literature.

Authors:  Annette Zimpfer; Albert Propst; Gregor Mikuz; Wolfgang Vogel; Luigi Terracciano; Sylvia Stadlmann
Journal:  Virchows Arch       Date:  2004-01       Impact factor: 4.064

Review 4.  Fluoroquinolone-induced liver injury: three new cases and a review of the literature.

Authors:  Anna Licata; Claudia Randazzo; Ilaria Morreale; Giuseppe Butera; Natale D'Alessandro; Antonio Craxì
Journal:  Eur J Clin Pharmacol       Date:  2012-01-14       Impact factor: 3.064

Review 5.  Idiosyncratic Drug-Induced Liver Injury Due to Ciprofloxacin: A Report of Two Cases and Review of the Literature.

Authors:  Milan Radovanovic; Tetyana Dushenkovska; Ivan Cvorovic; Natasa Radovanovic; Vimala Ramasamy; Katarina Milosavljevic; Jelena Surla; Mladen Jecmenica; Miroslav Radulovic; Tamara Milovanovic; Igor Dumic
Journal:  Am J Case Rep       Date:  2018-09-29

6.  Ciprofloxacin Exposure Leading to Fatal Hepatotoxicity: An Unusual Correlation.

Authors:  Carly Unger; Layth S Al-Jashaami
Journal:  Am J Case Rep       Date:  2016-09-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.